BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15245777)

  • 61. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mucinous gastric carcinomas: clinicopathologic and molecular analyses.
    Choi JS; Kim MA; Lee HE; Lee HS; Kim WH
    Cancer; 2009 Aug; 115(15):3581-90. PubMed ID: 19479974
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches.
    Scartozzi M; Galizia E; Freddari F; Berardi R; Cellerino R; Cascinu S
    Cancer Treat Rev; 2004 Aug; 30(5):451-9. PubMed ID: 15245777
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinico-pathological and biological prognostic factors in pleural malignant mesothelioma.
    O'Byrne KJ; Edwards JG; Waller DA
    Lung Cancer; 2004 Aug; 45 Suppl 1():S45-8. PubMed ID: 15261433
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic factors in gastric cancer.
    Allgayer H; Heiss MM; Schildberg FW
    Br J Surg; 1997 Dec; 84(12):1651-64. PubMed ID: 9448610
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy.
    McCarty MF
    Integr Cancer Ther; 2004 Dec; 3(4):349-80. PubMed ID: 15523106
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular targeting therapy for pancreatic cancer.
    Xiong HQ
    Cancer Chemother Pharmacol; 2004 Sep; 54 Suppl 1():S69-77. PubMed ID: 15316751
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Multifaceted roles of cyclooxygenase-2 in lung cancer.
    Riedl K; Krysan K; Põld M; Dalwadi H; Heuze-Vourc'h N; Dohadwala M; Liu M; Cui X; Figlin R; Mao JT; Strieter R; Sharma S; Dubinett SM
    Drug Resist Updat; 2004 Jun; 7(3):169-84. PubMed ID: 15296859
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention.
    Dannenberg AJ; Lippman SM; Mann JR; Subbaramaiah K; DuBois RN
    J Clin Oncol; 2005 Jan; 23(2):254-66. PubMed ID: 15637389
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition.
    Simmons DL; Botting RM; Hla T
    Pharmacol Rev; 2004 Sep; 56(3):387-437. PubMed ID: 15317910
    [TBL] [Abstract][Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.